Français
ItalianoBond Teva Pharma Industries 7.125% ( US88167AAN19 ) in USD
| Issuer | Teva Pharma Industries |
| Market price | 100.03 % ▲ |
| Country |  Israel
|
| ISIN code |
 US88167AAN19 ( in USD )
|
| Interest rate | 7.125% per year ( payment 2 times a year) |
| Maturity | 29/01/2025 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | / |
| Total amount | / |
| Cusip | 88167AAN1 |
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
| Moody's rating | Ba2 ( Non-investment grade speculative ) |
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. Teva Pharmaceutical Industries (ISIN: US88167AAN19, CUSIP: 88167AAN1) issued a USD-denominated bond currently trading at 99.133%, offering a 7.125% coupon with semi-annual payments, maturing on January 29, 2025, and rated BB- by S&P and Ba2 by Moody's. |